ManpowerGroup announced leadership changes with Becky Frankiewicz becoming CEO in 2027, reported Q3 2026 organic revenue growth of 6% year-over-year, and reaffirmed its $200 million permanent cost savings target by 2028. U.S. commercial staffing achieved its 9th consecutive quarter of double-digit revenue growth and market share gains, while the company increasingly deploys AI across 70% of global revenue to improve efficiency and client value.
MAN
ManpowerGroup · NYSE
Sign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about MAN?
Latest news
News ›ManpowerGroup (MAN) reported Q3 2026 earnings of $1.01 per share, matching consensus estimates, with revenues of $4.84 billion slightly missing expectations. The stock has gained 74.8% year-to-date, significantly outperforming the S&P 500's 12.8% gain. However, the company holds a Zacks Rank #3 (Hold) rating with mixed estimate revisions, and the Staffing Firms industry ranks in the bottom 26% of all industries, suggesting limited near-term upside.
ManpowerGroup (MAN) is experiencing growth fueled by strong Americas and Southern Europe revenues, with cost optimization targeting $200M in annual savings by 2028 and AI adoption expected to boost operating efficiency. However, the company faces headwinds from intense staffing market competition, AI-driven automation threats, and declining cash reserves that limit financial flexibility.
Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Board · $MAN · 0 threads
Sign in to post on $MAN
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.